CALORE, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 1.974
EU - Europa 1.606
AS - Asia 189
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 3.775
Nazione #
US - Stati Uniti d'America 1.973
IT - Italia 1.264
CN - Cina 139
UA - Ucraina 90
FI - Finlandia 71
SE - Svezia 56
FR - Francia 36
IN - India 30
DE - Germania 27
GB - Regno Unito 23
VN - Vietnam 13
IE - Irlanda 11
ES - Italia 6
CH - Svizzera 5
BE - Belgio 3
PL - Polonia 3
BR - Brasile 2
EU - Europa 2
HK - Hong Kong 2
JP - Giappone 2
NL - Olanda 2
RO - Romania 2
RU - Federazione Russa 2
AL - Albania 1
AT - Austria 1
BH - Bahrain 1
BY - Bielorussia 1
CA - Canada 1
EG - Egitto 1
GR - Grecia 1
IR - Iran 1
PE - Perù 1
SI - Slovenia 1
TR - Turchia 1
Totale 3.775
Città #
Fairfield 241
Chandler 239
Ann Arbor 168
Woodbridge 152
Houston 131
Ashburn 115
Seattle 102
Jacksonville 97
Rome 84
Wilmington 84
Milan 79
Cambridge 61
Beijing 56
Des Moines 49
Helsinki 44
Princeton 39
Medford 33
San Diego 31
Florence 29
Padova 28
Roxbury 26
Nanjing 19
Naples 18
Boardman 16
New York 15
Palermo 15
Dong Ket 13
Cagliari 12
Verona 12
Bologna 11
Dublin 11
Napoli 11
Los Angeles 10
Redwood City 10
Trento 10
Perugia 9
Pisa 9
Bari 8
Turin 8
Shenyang 7
Brescia 6
Dallas 6
Hefei 6
Mumbai 6
Norwalk 6
Bergamo 5
Changsha 5
Guangzhou 5
Lucca 5
Monza 5
Rochester 5
Trieste 5
Udine 5
Boves 4
Bussolengo 4
Castellammare di Stabia 4
Falls Church 4
Genoa 4
Jiaxing 4
Jinan 4
Livorno 4
Menlo Park 4
Pescara 4
Spinea 4
Taranto 4
Treviso 4
Villa Carcina 4
Afragola 3
Andover 3
Bisceglie 3
Bogogno 3
Campogalliano 3
Cantù 3
Capua 3
Castel Maggiore 3
Castelfranco di Sotto 3
Cervia 3
Crotone 3
Dosimo 3
Duncan 3
Ercolano 3
Frosinone 3
Guardiagrele 3
Hangzhou 3
Monterotondo 3
Nanchang 3
Nettuno 3
Paris 3
Pavia 3
Prato 3
Rimini 3
Sant'Angelo in Vado 3
Torino 3
Torreglia 3
Varese 3
Zhengzhou 3
Alessandria 2
Annone Veneto 2
Arcore 2
Ardea 2
Totale 2.333
Nome #
Ruolo dell'NT-proBNP nella cardiomiopatia ipertrofica 565
Ruolo della risonanza magnetica cardiaca nella stratificazione prognostica dei pazienti con cardiomiopatia ipertrofica 531
Screening di mutazioni patogene nei quattro geni più frequentemente implicati nella cardiomiopatia ipertrofica 412
Ricerca di mutazioni patogene in pazienti affetti da cardiomiopatia ipertrofica: risultati dello screening genetico per 12 geni con tecnica di DNA resequencing array. 179
Study of the microcirculation in hDAF transgenic rat livers xenoperfused with human blood. 116
Accuracy of the ECG for differential diagnosis between hypertrophic cardiomyopathy and athlete's heart: comparison between the European Society of Cardiology (2010) and International (2017) criteria 116
Genetic modifiers of Duchenne muscular dystrophy and dilated cardiomyopathy 115
Clinicopathologicalprofiles of progressive heart failure in hypertrophic cardiomyopathy. 114
Electrocardiographic anterior T-wave inversion in athletes of different ethnicities: Differential diagnosis between athlete's heart and cardiomyopathy 106
Muscle MRI and functional outcome measures in Becker muscular dystrophy 102
Radial function correlates with heart failure symptoms in hypertrophic cardiomyopathy with normal ejection fraction 99
The clinical spectrum of CASQ1-related myopathy 81
Co-inheritance of mutations associated with arrhythmogenic cardiomyopathy and hypertrophic cardiomyopathy 77
Cardiovascular magnetic resonance signs of ischemia in hypertrophic cardiomyopathy. 72
Marginal Overlap between Electrocardiographic Abnormalities in patients with Hypertrophic Cardiomyopathy and Trained Athletes: Implications for Preparticipation Screening. 70
Relationship of 3D left ventricular mass with systolic and diastolic function indices in hypertrophic cardiomyopathy 67
Hypertrophic Cardiomyopathy and Primary Restrictive Cardiomyopathy: Similarities, Differences and Phenocopies 64
Utilità della diagnostica non invasiva ed invasiva nella stratificazione del rischio aritmico ipo ed ipercinetico nella Distrofia Miotonica tipo I. 61
Left ventricular outflow tract planimetry by 3D echocardiography predicts obstruction and heart failure symptoms in hypertrophic cardiomyopathy 60
"Hot phase" nella cardiomiopatiaipertrofica?Ruolo delle troponine ad alta sensibilità. 57
Myocardial damage biomarkers in hypertrophic cardiomyopathy: prognostic role of high sensitivity cardiac troponin I and T. 57
Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up 57
Three-dimensional myocardial strain patterns in patients with physiological and pathological hypertrophy and preserved left ventricular systolic function: a comparative study 56
Prevalence and echocardiographic features of a normal electrocardiogram in patients with hypertrophic cardiomyopathy: implications for pre-participation screening 53
Quantitative analysis of mitral valve geometry by transthoracic three-dimensional echocardiography: reference values, feasibility and reproducibility 52
Mitral valve abnormalities correlate with left ventricular remodelling and obstruction in hypertrophic cardiomyopathy: a quantitative 3D transthoracic echocardiographic study 51
Role of “Ischemia Modified Albumin” in detecting myocardial ischemia in hypertrophic cardiomyopathy. 50
ROLE OF "ISCHEMIA MODIFIED ALBUMIN" IN DETECTING MYOCARDIAL ISCHEMIA IN HYPERTROPHIC CARDIOMYOPATHY 48
The role of non-invasive methods in determining the arrhythmic risk in myotonic dystrophy type 1 47
DNA resequencing array for mutation detection in hypertrophic cardiomyopathy 46
Genotype-phenotype correlations and genetic family screening in hypertrophic cardiomyopathy 45
Mitral leaflet sizing in hypertrophic cardiomyopathy: impact of method and timing 43
Clinical meaning of isolated increase of QRS voltages in hypertrophic cardiomyopathy versus athlete's heart 39
Characterisation of transmural longitudinal and circumferential mechanics by multi-layer strain analysis in hypertrophic cardiomyopathy 37
In patients with hypertrophic cardiomyopathy, left ventricular mass and shape by three-dimensional echocardiography are related with dynamic obstruction and functional capacity 35
Left atrial longitudinal strain correlates better than its emptying fraction with left ventricular impairment in hypertrophic cardiomyopathy 34
Reply to the Editor—Mexiletine in myotonic dystrophy: Beware of ventricular arrhythmias! 12
Totale 3.826
Categoria #
all - tutte 9.205
article - articoli 5.326
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.531


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019124 0 0 0 0 0 0 0 0 0 34 46 44
2019/2020608 71 26 16 41 56 45 51 68 53 61 68 52
2020/2021622 34 53 35 48 55 42 31 43 77 58 96 50
2021/2022613 39 90 32 61 38 49 30 55 32 29 42 116
2022/2023784 97 70 60 91 127 116 25 44 65 25 42 22
2023/2024487 25 50 69 57 49 59 28 54 42 54 0 0
Totale 3.826